Skip to main content
Springer Nature Link
Log in

Quality Measures for the Care of Patients with Insomnia

  • Special Section
  • Published:
Save article
View saved research
Journal of Clinical Sleep Medicine Aims and scope Submit manuscript

Abstract

The American Academy of Sleep Medicine (AASM) commissioned five Workgroups to develop quality measures to optimize management and care for patients with common sleep disorders including insomnia. Following the AASM process for quality measure development, this document describes measurement methods for two desirable outcomes of therapy, improving sleep quality or satisfaction, and improving daytime function, and for four processes important to achieving these goals. To achieve the outcome of improving sleep quality or satisfaction, pre- and post-treatment assessment of sleep quality or satisfaction and providing an evidence-based treatment are recommended. To realize the outcome of improving daytime functioning, pre- and post-treatment assessment of daytime functioning, provision of an evidence-based treatment, and assessment of treatment-related side effects are recommended. All insomnia measures described in this report were developed by the Insomnia Quality Measures Workgroup and approved by the AASM Quality Measures Task Force and the AASM Board of Directors. The AASM recommends the use of these measures as part of quality improvement programs that will enhance the ability to improve care for patients with insomnia.

Citation:

Edinger JD, Buysse DJ, Deriy L, Germain A, Lewin DS, Ong JC, Morgenthaler TI. Quality measures for the care of patients with insomnia. J Clin Sleep Med 2015;11(3):311–334.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
The alternative text for this image may have been generated using AI.

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

REFERENCES

  1. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.

    Google Scholar 

  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.

    Google Scholar 

  3. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225–32.

    Google Scholar 

  4. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479–84.

    Google Scholar 

  5. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep 1999;22Suppl 2:S366–372.

    Google Scholar 

  6. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997;31:333–46.

    Google Scholar 

  7. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123–30.

    Google Scholar 

  8. Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry 2011;69:592–600.

    Google Scholar 

  9. Calhoun SL, Fernandez-Mendoza J, Vgontzas AN, Liao D, Bixler EO. Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects. Sleep Med 2014;15:91–95.

    Google Scholar 

  10. Roberts RE, Roberts CR, Duong HT. Chronic insomnia and its negative consequences for health and functioning of adolescents: a 12-month prospective study. J Adolesc Health 2008;42:294–302.

    Google Scholar 

  11. Richardson GS. Managing insomnia in the primary care setting: raising the issues. Sleep 2000;23Suppl 1:S9–12 discussion S13–15.

    Google Scholar 

  12. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158:1099–107.

    Google Scholar 

  13. Lacks P, Morin C. Recent advances in the assessment and treatment of insomnia. J Consult Clin Psychol 1992;60:586–94.

    Google Scholar 

  14. Fichten CS, Libman E, Bailes S, Alapin I. Characteristics of older adults with insomnia. In: Lichtstein KL, Morin CM, eds. Treatment of late-life insomnia. Thousand Oaks, CA: Sage, 2000:37–80.

    Google Scholar 

  15. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22:S379–85.

    Google Scholar 

  16. Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand 1987;221:475–81.

    Google Scholar 

  17. Vollrath M, Wicki W, Angst J. The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci 1989;239:113–24.

    Google Scholar 

  18. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105–14.

    Google Scholar 

  19. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996;39:411–8.

    Google Scholar 

  20. Johnson EO, Roehrs T, Roth T, Breslau N. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 1998;21:178–86.

    Google Scholar 

  21. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417–23.

    Google Scholar 

  22. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997;19:245–50.

    Google Scholar 

  23. Buysse DJ, Tu XM, Cherry CR, et al. Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry 1999;45:205–13.

    Google Scholar 

  24. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221–5.

    Google Scholar 

  25. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 1997;42:209–12.

    Google Scholar 

  26. Agargun MY, Kara H, Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 1997;58:249–51.

    Google Scholar 

  27. Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 2006;40:700–8.

    Google Scholar 

  28. Palermo TM, Wilson AC, Lewandowski AS, Toliver-Sokol M, Murray CB. Behavioral and psychosocial factors associated with insomnia in adolescents with chronic pain. Pain 2011;152:89–94.

    Google Scholar 

  29. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22:S386–93.

    Google Scholar 

  30. Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009;32:55–64.

    Google Scholar 

  31. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487–504.

    Google Scholar 

  32. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155–73.

    Google Scholar 

  33. Morgenthaler TI. The quest for stability in an unstable world: adaptive servoventilation in opioid induced complex sleep apnea syndrome. J Clin Sleep Med 2008;4:321–3.

    Google Scholar 

  34. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). Sleep 2006;29:1398–414.

    Google Scholar 

  35. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793–9.

    Google Scholar 

  36. Roehrs TA, Randall S, Harris E, Maan R, Roth T. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol 2012;26:1088–95.

    Google Scholar 

  37. Buysse DJ, Young T, Edinger JD, Carroll J, Kotagal S. Clinician's use of the International Classification of Sleep Disorders (ICSD): results of a national survey. Sleep 2003;26:48–51.

    Google Scholar 

  38. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 2006;29:1415–9.

    Google Scholar 

  39. National Institutes of Health National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005;28:1049–57.

    Google Scholar 

  40. Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010;24:1577–601.

    Google Scholar 

  41. Perlis ML, Smith MT. How can we make CBT-I and other BSM services widely available. J Clin Sleep Med 2008;4:11–13.

    Google Scholar 

  42. Espie CA. “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009;32:1549–58.

    Google Scholar 

  43. Edinger JD. Is it time to step up to stepped care with our cognitive-behavioral insomnia therapies? Sleep 2009;32:1539–41.

    Google Scholar 

  44. Manber R, Carney C, Edinger J, et al. Dissemination of CBTI to the non-sleep specialist: protocol development and training issues. J Clin Sleep Med 2012;8:209–18.

    Google Scholar 

  45. Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L, Baum LD. Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psycho-oncology 2012;21:695–705.

    Google Scholar 

  46. Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012;35:769–81.

    Google Scholar 

  47. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999;22:371–5.

    Google Scholar 

  48. Morgenthaler TI, Aronsky AJ, Carden KA, Chervin RD, Thomas SM, Watson NF. Measurement of quality to improve care in sleep medicine. J Clin Sleep Med 2015;11:279–91.

    Google Scholar 

  49. Southam-Gerow MA, Weisz JR, Chu BC, McLeod BD, Gordis EB, Connor-Smith JK. Does cognitive behavioral therapy for youth anxiety outperform usual care in community clinics? An initial effectiveness test. J Am Acad Child Adolesc Psychiatry 2010;49:1043–52.

    Google Scholar 

  50. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2005(4):CD004690.

  51. Cummings CM, Caporino NE, Settipani CA, et al. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. J Consult Clin Psychol 2013;81:859–64.

    Google Scholar 

  52. Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep 2000;23:1043–51.

    Google Scholar 

  53. Owens JA, Maxim R, Nobile C, McGuinn M, Msall M. Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2000;154:549–55.

    Google Scholar 

  54. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297–307.

    Google Scholar 

  55. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.

    Google Scholar 

  56. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45:5–13.

    Google Scholar 

  57. Hedges DW, Brown BL, Shwalb DA. A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder. Hum Psychopharmacol 2009;24:35–40.

    Google Scholar 

  58. Bruni O, Ottaviano S, Guidetti V, et al. The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res 1996;5:251–61.

    Google Scholar 

  59. Wolfson AR, Carskadon MA, Acebo C, et al. Evidence for the validity of a sleep habits survey for adolescents. Sleep 2003;26:213–6.

    Google Scholar 

  60. Carney CE, Buysse DJ, Ancoli-Israel S, et al. The Consensus Sleep Diary: standardizing prospective sleep self-monitoring. Sleep 2012;35:287–302.

    Google Scholar 

  61. Kowalik J, Weller J, Venter J, Drachman D. Cognitive behavioral therapy for the treatment of pediatric posttraumatic stress disorder: a review and meta-analysis. J Behav Ther Exp Psychiatry 2011;42:405–13.

    Google Scholar 

  62. Rapp A, Dodds A, Walkup JT, Rynn M. Treatment of pediatric anxiety disorders. Ann N Y Acad Sci 2013;1304:52–61.

    Google Scholar 

  63. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007;22:1335–50.

    Google Scholar 

  64. Buysse DJ. Insomnia. JAMA 2013;309:706–16.

    Google Scholar 

  65. Krakow B, Melendrez D, Lee SA, Warner TD, Clark JO, Sklar D. Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath 2004;8:15–29.

    Google Scholar 

  66. Guilleminault C, Davis K, Huynh NT. Prospective Randomized study of patients with insomnia and mild sleep disordered breathing. Sleep 2008;31:1527–33.

    Google Scholar 

  67. Edinger J, Bonnet M, Bootzin R, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 2004;27:1567–96.

    Google Scholar 

  68. Anderson B, Storfer-Isser A, Taylor HG, Rosen CL, Redline S. Associations of executive function with sleepiness and sleep duration in adolescents. Pediatrics 2009;123:e701–707.

    Google Scholar 

  69. Gruber R, Laviolette R, Deluca P, Monson E, Cornish K, Carrier J. Short sleep duration is associated with poor performance on IQ measures in healthy school-age children. Sleep Med 2010;11:289–94.

    Google Scholar 

  70. Baum KT, Desai A, Field J, Miller LE, Rausch J, Beebe DW. Sleep restriction worsens mood and emotion regulation in adolescents. J Child Psychol Psychiatry 2014;55:180–90.

    Google Scholar 

  71. Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev 2003;7:263–79.

    Google Scholar 

  72. Buysse DJ, Cheng Y, Germain A, et al. Night-to-night sleep variability in older adults with and without chronic insomnia. Sleep Med 2010;11:56–64.

    Google Scholar 

  73. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–5.

    Google Scholar 

  74. Krupp LB, Larocca NG, Muirnash J, Steinberg AD. The fatigue severity scale - application to patients with multiple-sclerosis and systemic lupuserythematosus. Arch Neurol 1989;46:1121–3.

    Google Scholar 

  75. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315–25.

    Google Scholar 

  76. Beck AT, Steer RA, Garbin MG. Psycometric properties of the Beck Depression Inventory - 25 years of evaluation. Clin Psychol Rev 1988;8:77–100.

    Google Scholar 

  77. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.

    Google Scholar 

  78. Radloff LS. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. J Youth Adolesc 1991;20:149–66.

    Google Scholar 

  79. McNair DM, Lorr M, Droppleman LF. Profile of Mood States Manual. San Diego, CA: Educational and Industrial Testing Service, 1971.

    Google Scholar 

  80. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.

    Google Scholar 

  81. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7.

    Google Scholar 

  82. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11Suppl 3:89–95.

    Google Scholar 

  83. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.

    Google Scholar 

  84. Johnson JA, Maddigan SL. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Qual Life Res 2004;13:449–56.

    Google Scholar 

  85. Melendres MC, Lutz JM, Rubin ED, Marcus CL. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 2004;114:768–75.

    Google Scholar 

  86. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999;37:126–39.

    Google Scholar 

  87. Cohen M. The Revised Conners Parent Rating Scale: factor structure replication with a diversified clinical sample. J Abnorm Child Psychol 1988;16:187–96.

    Google Scholar 

  88. Wren FJ, Berg EA, Heiden LA, et al. Childhood anxiety in a diverse primary care population: parent-child reports, ethnicity and SCARED factor structure. J Am Acad Child Adolesc Psychiatry 2007;46:332–40.

    Google Scholar 

  89. Hodges KK, Siegel LJ, Mullins L, Griffin N. Factor analysis of the Children's Depression Inventory. Psychol Rep 1983;533 Pt 1:759–63.

    Google Scholar 

  90. Achenbach TM, Edelbrock CS. Behavioral problems and competencies reported by parents of normal and disturbed children aged four through sixteen. Monogr Soc Res Child Dev 1981;46:1–82.

    Google Scholar 

  91. Kyle SD, Miller CB, Rogers Z, Siriwardena AN, Macmahon KM, Espie CA. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep 2014;37:229–37.

    Google Scholar 

  92. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169.

    Google Scholar 

  93. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008;9:818–22.

    Google Scholar 

  94. Lader M. Benzodiazepines revisited--will we ever learn? Addiction 2011;106:2086–109.

    Google Scholar 

  95. Roehrs T, Roth T. Drug-related sleep stage changes: functional significance and clinical relevance. Sleep Med Clin 2010;5:559–70.

    Google Scholar 

  96. Greenblatt DJ, Roth T. Zolpidem for insomnia. Expert Opin Pharmacother 2012;13:879–93.

    Google Scholar 

  97. Gunja N. In the Zzz zone: the effects of Z-drugs on human performance and driving. J Med Toxicol 2013;9:163–71.

    Google Scholar 

Download references

ACKNOWLEDGMENTS

The American Academy of Sleep Medicine would like to thank the following parties for their review of these measures, and for providing feedback and suggestions to improve the relevancy and utility of these measures in their field of practice: Ruth Boland, RN; Barry Krakow, MD; Bonnie Norris, RN; William Sherrill Jr., MD; Krishna Sundar, MD; Charles Wells, MD; Reed Young, MD; American Academy of Family Physicians (AAFP). The AASM did not seek or receive endorsement of these measures from any of the reviewers who provided feedback. The authors carefully considered all feedback provided, and implemented as many suggestions as were feasible in the refining of these measures. We would also like to thank Carolyn Winter-Rosenberg, AASM Director of Coding and Compliance, for guidance in compiling the technical specifications associated with these quality measures.

Author information

Authors and Affiliations

  1. National Jewish Health, Denver, CO, USA

    Jack D. Edinger PhD

  2. Duke University Medical Center, Durham, NC, USA

    Jack D. Edinger PhD

  3. University of Pittsburgh Medical School, Pittsburgh, PA, USA

    Daniel J. Buysse MD & Anne Germain PhD

  4. American Academy of Sleep Medicine, Darien, IL, USA

    Ludmila Deriy PhD

  5. Children's National Medical Center, Washington, DC, USA

    Daniel S. Lewin PhD

  6. Rush University Medical Center, Chicago, IL, USA

    Jason C. Ong PhD

  7. Mayo Clinic, Rochester, MN, USA

    Timothy I. Morgenthaler MD

Authors
  1. Jack D. Edinger PhD
    View author publications

    Search author on:PubMed Google Scholar

  2. Daniel J. Buysse MD
    View author publications

    Search author on:PubMed Google Scholar

  3. Ludmila Deriy PhD
    View author publications

    Search author on:PubMed Google Scholar

  4. Anne Germain PhD
    View author publications

    Search author on:PubMed Google Scholar

  5. Daniel S. Lewin PhD
    View author publications

    Search author on:PubMed Google Scholar

  6. Jason C. Ong PhD
    View author publications

    Search author on:PubMed Google Scholar

  7. Timothy I. Morgenthaler MD
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Jack D. Edinger PhD.

Additional information

Address correspondence to: Jack D. Edinger, PhD, Division of Pulmonology, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206; Email: edingerj@njhealth.org

APPENDIX

APPENDIX

The following are the technical specifications for the insomnia quality measures, which can be used to calculate an individual provider's performance in meeting these measures. Tracking and periodically reviewing this performance data will help providers identify opportunities for improvement within their own practices.

Outcome Measure #1: Improve sleep satisfaction/quality

Process Measure #1: Assessment of sleep quality

Process Measure #2: Delivery of evidence-based treatment

Outcome Measure #2: Improve daytime functioning

Process Measure #3: Assessment of daytime functioning

Process Measure #4: Assessment of side effects of treatments

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edinger, J., Buysse, D., Deriy, L. et al. Quality Measures for the Care of Patients with Insomnia. J Clin Sleep Med 11, 311–334 (2015). https://doi.org/10.5664/jcsm.4552

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.5664/jcsm.4552